Ms Preetha Reddy (Executive Vice Chairman AHEL), Dr Prathap Reddy (Chairman AHEL), Olivier Legrain (CEO IBA) & Dr Rakesh Jalali (Clinical Director APCC)

August 19, 2022 —  IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancerannounces it has signed a collaboration agreement with Apollo Hospitals Enterprise Ltd (AHEL), to provide proton therapy training and education programs for IBA customers in Asia. 

AEHL is a long-term customer of IBA, purchasing a ProteusPLUS[1] proton therapy system in 2013 and successfully utilizing it in the treatment of cancer patients for more than three years. Since AHEL started its proton therapy operations at Apollo Proton Cancer Centres (APCC), it has gained significant expertise and experience in treating a wide range of tumor types IBA plans to leverage this experience, working with AEHL to provide a training and education program initiative, to aspiring proton therapy users in Asia and other parts of the world. 

Olivier Legrain, Chief Executive Officer at IBA, said: "Over recent years, Apollo Hospitals has shown its expertise and enthusiasm by successfully organizing training symposia for the local and international proton therapy experts’ community. We look forward to collaborating with Apollo in order to provide high-quality training and education to our customers and prospects in Asia without them traveling to another continent." 

Dr. Prathap C Reddy, Founder and Chairman of Apollo Hospitals Enterprise Ltd, said: "An acute need for high-quality cancer care, coupled with an increasing prevalence of cancer cases in India, led to the creation of Apollo Cancer Centres (ACC) around three decades ago. Since then, ACC has continually introduced the finest and most advanced cancer care into India, with the most recent being bringing Proton Therapy to the region. Furthermore, in keeping with its resolute mission to raise the bar in cancer care for all in need, in association with IBA, the Apollo Proton Cancer Centre will be the first of its kind training and education program reference centre in Asia. 

For more information: www.iba-worldwide.com 

[1] ProteusPLUS is the brand name of IBA Proteus235. 


Related Content

News | Radiopharmaceuticals and Tracers

Nov. 11, 2025 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has released a position paper outlining ...

Time November 12, 2025
arrow
News | Stereotactic Body Radiation Therapy (SBRT) | American Society for Radiation Oncology

Sept. 29, 2025 — A new clinical trial report finds that stereotactic radiation therapy offers long-term survival ...

Time October 15, 2025
arrow
News | Proton Therapy

Sept. 28, 2025 — Leo Cancer Care has launched Grace, the company's upright photon therapy system. Grace is named after ...

Time October 03, 2025
arrow
News | Radiation Therapy | American Society for Radiation Oncology (ASTRO)

Sept. 29, 2025 — Radiation therapy may offer a comparable and potentially safer alternative to repeat catheter ablation ...

Time September 30, 2025
arrow
News | Radiation Therapy

Sept. 26, 2025 – Accuray Inc. has introduced the Accuray Stellar* solution. Initially for the U.S. market, the new ...

Time September 29, 2025
arrow
News | Computed Tomography (CT)

Sept. 26, 2025 — At the American Society for Radiation Oncology (ASTRO) 2025 annual meeting in San Francisco, Calif ...

Time September 29, 2025
arrow
News | Lung Imaging

Sept. 26, 2025 ― Researchers from the University of Texas MD Anderson Cancer Center will present new data at the ...

Time September 29, 2025
arrow
News | ASTRO

Sept. 26, 2025 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive ...

Time September 29, 2025
arrow
News | Radiation Therapy

Sept. 25, 2025 — GE HealthCare has announced updates to Intelligent Radiation Therapy (iRT), a new version of the ...

Time September 25, 2025
arrow
News | ASTRO

Sept. 10, 2025 — ZAP Surgical Systems, Inc. will make its debut at the 2025 ASTRO (American Society for Radiation ...

Time September 12, 2025
arrow
Subscribe Now